RPG Life Sciences Share Price in Focus; Invests ₹65.68 Crore in RPG Active Pharma

On August 15, 2026, RPG Life Sciences Limited announced an investment of ₹65,68,60,500 in RPG Active Pharma Limited, a wholly owned subsidiary, as per the exchange filings.  

The investment was made through a subscription in a rights issue of equity shares, ensuring the company's continued 100% ownership of RPG Active Pharma. 

Investment Details and Structure 

The investment in RPG Active Pharma Limited was executed through a rights issue, with RPG Life Sciences subscribing to 21,89,535 equity shares at a face value of ₹10 each.  

The total investment amounting to ₹65,68,60,500 was facilitated through cash consideration via normal banking channels. 

Related Party Transaction and Compliance 

This transaction falls under related party transactions as per Section 177 of the Companies Act, 2013, and Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It was carried out at arm's length, with no additional interest from the promoter group beyond the subsidiary relationship. 

RPG Active Pharma Limited Overview 

RPG Active Pharma Limited, incorporated on December 24, 2025, is a public company based in Mumbai, India. As a wholly owned subsidiary of RPG Life Sciences, it has an authorised share capital of ₹7,00,00,000 and a paid-up capital of ₹1,16,85,000. The company is yet to commence operations and currently reports no turnover. 

RPG Active Pharma operates within the pharmaceutical industry, aligning with the parent company's main line of business. The investment ensures RPG Life Sciences retains full control over the subsidiary, with the shareholding remaining at 100% post-investment. 

Read More: Anupam Rasayan India Share Price in Focus After Q1 FY27 Earnings Results: Total Income Up 36% YoY! 

RPG Life Sciences Share Price Performance 

As of August 14, 2026, at 3:30 PM, RPG Life Sciences share price on NSE was closed at ₹2,782.30, down by 1.70% from the previous closing price. 

Conclusion 

RPG Life Sciences' investment of ₹65,68,60,500 in RPG Active Pharma Limited through a rights issue maintains its 100% ownership. RPG Active Pharma, incorporated in December 2025, is yet to begin operations and has no turnover. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.